X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | P - Purchase | $18.00 | +3,600,000 | 21,826,024 | +20% | +$64,800,000 | |||||
| D | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% | P - Purchase | $17.00 | +600,000 | 2,165,708 | +38% | +$10,200,000 | |||||
2026-08-06 | SCISX | Ma Specialty Credit Income Fund | Ma Eagle II Holdings Fund | 10% | P - Purchase | $24.71 | +404,694 | 3,568,254 | +13% | +$10,000,000 | ||||||
| D | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Sanofi | 10% | P - Purchase | $17.00 | +300,000 | 1,082,855 | +38% | +$5,100,000 | |||||
| M | 2026-08-05 | ABTC | American Bitcoin Corp. | Mateen Justin | Dir | P - Purchase | $6.29 | +306,981 | 492,297 | +166% | +$1,929,607 | |||||
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Viehbacher Christopher | Dir | P - Purchase | $18.00 | +83,333 | 759,857 | +12% | +$1,499,994 | |||||
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Murdoch Travis | CEO, Pres | P - Purchase | $18.00 | +83,333 | 8,333,637 | +1% | +$1,499,994 | |||||
2026-07-30 | ONMD | Onemednet Corp | Kosasa Thomas | Dir, 10% | P - Purchase | $0.69 | +1,449,275 | 18,538,150 | +8% | +$1,000,000 | ||||||
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Lubner David Charles | Dir | P - Purchase | $18.00 | +55,555 | 55,555 | New | +$999,990 | |||||
| M | 2026-08-05 | AAT | American Assets Trust, Inc. | Rady Ernest S | Exec COB, 10% | P - Purchase | $22.84 | +35,763 | 13,585,206 | 0% | +$816,772 | |||||
| M | 2026-08-05 | CCB | Coastal Financial Corp | Hovde Steven D | Dir, 10% | P - Purchase | $43.88 | +15,000 | 1,743,793 | +1% | +$658,250 | |||||
2026-08-05 | GBFH | Gbank Financial Holdings Inc. | Griege Charles William Jr. | Dir | P - Purchase | $21.03 | +25,000 | 511,681 | +5% | +$525,675 | ||||||
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Rickey James Paul | CFO | P - Purchase | $18.00 | +27,777 | 703,575 | +4% | +$499,986 | |||||
2026-08-06 | CCB | Coastal Financial Corp | Sprink Eric M | CEO | P - Purchase | $44.45 | +10,000 | 175,323 | +6% | +$444,500 | ||||||
2026-08-06 | DGICA | Donegal Group Inc | Donegal Mutual Insurance Co | 10% | P - Purchase | $19.67 | +18,000 | 18,906,665 | 0% | +$354,060 | ||||||
| M | 2026-08-05 | NMM | Navios Maritime Partners L.P. | Frangou Angeliki | See Remarks, 10% | P - Purchase | $78.96 | +3,181 | 5,776,804 | 0% | +$251,170 | |||||
2026-08-05 | BSX | Boston Scientific Corp | Habiger David C | Dir | P - Purchase | $47.59 | +2,100 | 17,160 | +14% | +$99,937 | ||||||
2026-08-06 | BBBY | Bed Bath & Beyond, Inc. | Tabacco Joseph J Jr | Dir | P - Purchase | $4.57 | +20,000 | 225,588 | +10% | +$91,400 | ||||||
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Malek David I | Dir | P - Purchase | $18.00 | +4,166 | 1,013,297 | 0% | +$74,988 | |||||
2026-08-06 | ADTN | Adtran Holdings, Inc. | Santo Timothy P | SVP of Finance; CFO | P - Purchase | $7.60 | +6,579 | 59,924 | +12% | +$50,000 | ||||||
| A | 2026-07-21 | TLSA | Tiziana Life Sciences Ltd | Cerrone Gabriele M | Dir, 10% | P - Purchase | $0.99 | +42,357 | 44,814,587 | 0% | +$41,933 | |||||
| A | 2026-07-20 | OKYO | Okyo Pharma Ltd | Cerrone Gabriele M | Dir, 10% | P - Purchase | $1.40 | +25,000 | 10,851,416 | 0% | +$35,000 | |||||
| A | 2026-07-21 | OKYO | Okyo Pharma Ltd | Cerrone Gabriele M | Dir, 10% | P - Purchase | $1.45 | +22,500 | 10,873,916 | 0% | +$32,625 | |||||
| M | 2026-08-06 | LARK | Landmark Bancorp Inc | Kohlrus Mark J. | Dir | P - Purchase | $31.77 | +1,000 | 4,434 | +29% | +$31,767 | |||||
2026-08-05 | PMN | Promis Neurosciences Inc. | Kaplan Johanne | Chief Development Officer | P - Purchase | $13.30 | +2,280 | 6,221 | +58% | +$30,324 | ||||||
| A | 2026-07-21 | OKYO | Okyo Pharma Ltd | Mantelli Flavio | CHIEF MEDICAL OFFICER | P - Purchase | $1.40 | +20,000 | 20,000 | New | +$28,000 | |||||
2026-08-05 | ETD | Ethan Allen Interiors Inc | Tsai Cynthia Ekberg | Dir | P - Purchase | $24.61 | +1,000 | 2,306 | +77% | +$24,610 | ||||||
| M | 2026-08-05 | APCX | Apptech Payments Corp. | Lord Albert L | Dir | P - Purchase | $0.40 | +60,000 | 1,100,000 | +6% | +$23,814 | |||||
| A | 2026-07-22 | OKYO | Okyo Pharma Ltd | Dempsey Robert John | CEO | P - Purchase | $1.54 | +15,000 | 15,000 | New | +$23,085 | |||||
| D | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Anderson Michele A. | Chief Development Officer | P - Purchase | $18.00 | +1,111 | 332,161 | 0% | +$19,998 | |||||
| M | 2026-08-05 | FNRN | First Northern Community Bancorp | Servat Jean-Luc | Dir | P - Purchase | $18.22 | +1,000 | 4,635 | +28% | +$18,221 | |||||
| A | 2026-06-12 | TLSA | Tiziana Life Sciences Ltd | Cerrone Gabriele M | Dir, 10% | P - Purchase | $1.11 | +15,000 | 44,772,230 | 0% | +$16,650 | |||||
2026-08-06 | ENBP | Enb Financial Corp | Zimmerman Roger L | Dir | P - Purchase | $29.48 | +500 | 5,064 | +11% | +$14,740 | ||||||
2026-08-06 | BBBY | Bed Bath & Beyond, Inc. | Shapiro Robert Jacob | Dir | P - Purchase | $4.51 | +3,000 | 70,107 | +4% | +$13,530 | ||||||
2026-08-07 | CCB | Coastal Financial Corp | Adams Christopher D | Exec Chair | P - Purchase | $45.15 | +290 | 30,407 | +1% | +$13,094 | ||||||
| M | 2026-08-05 | AWRE | Aware Inc /Ma/ | Amlani Ajay K | Pres, CEO | P - Purchase | $1.24 | +10,069 | 959,506 | +1% | +$12,486 | |||||
2026-08-06 | TLRY | Tilray Brands, Inc. | Gendel Mitchell | Global GC | P - Purchase | $4.43 | +2,500 | 124,883 | +2% | +$11,075 | ||||||
| M | 2026-08-06 | DLHC | Dlh Holdings Corp. | Mink Brook Asset Management LLC | 10% | P - Purchase | $4.82 | +1,956 | 2,868,492 | 0% | +$9,431 | |||||
2026-08-05 | NWPP | New Peoples Bankshares Inc | White Blaine Scott | Dir, 10% | P - Purchase | $4.35 | +1,716 | 5,656,330 | 0% | +$7,465 | ||||||
| A | 2026-07-21 | OKYO | Okyo Pharma Ltd | Brancaccio John P | Dir | P - Purchase | $1.48 | +5,000 | 35,201 | +17% | +$7,385 | |||||
2026-07-03 | VALE | Vale S.A. | De Souza Funo Elaine Maria | Accounting Officer | P - Purchase | $15.25 | +406 | 32,262 | +1% | +$6,192 | ||||||
| A | 2026-07-27 | OKYO | Okyo Pharma Ltd | Patil Rajkumar V. | Chief Scientific Officer | P - Purchase | $1.49 | +3,363 | 20,030 | +20% | +$5,011 | |||||
| A | 2026-07-21 | OKYO | Okyo Pharma Ltd | Jacob Gary S | CHIEF DEVELOPMENT OFFICER | P - Purchase | $1.40 | +3,500 | 112,420 | +3% | +$4,900 | |||||
2026-08-07 | FUSB | First Us Bancshares, Inc. | Pierce Staci | Dir | P - Purchase | $16.51 | +245 | 10,850 | +2% | +$4,045 | ||||||
2026-08-06 | RCG | Renn Fund, Inc. | Horizon Kinetics Asset Management LLC | 10% | P - Purchase | $2.97 | +756 | 947,784 | 0% | +$2,245 | ||||||
2026-08-06 | TPL | Texas Pacific Land Corp | Horizon Kinetics Asset Management LLC | 10% | P - Purchase | $355.62 | +1 | 3,244,004 | 0% | +$356 | ||||||
| D | 2026-08-06 | JSDA | Jones Soda Co. | Meadows Brian | CFO | P - Purchase | $0.00 | +303,030 | 303,030 | New | +$0 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |